Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy

Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy

BACKGROUND: Patients who are prescribed specialty medications require close monitoring, including assessment of laboratory parameters, toxicities, and adherence. Specialty pharmacies integrated within a health system are able to access records, assess therapy, and efficiently communicate with prescr...

Full description

Bibliographic Details
Main Authors: Dura, J. (Author), Geyer, K. (Author), Lam, S.W (Author), Lankford, C. (Author), Naelitz, B. (Author), Tran, A. (Author), Willner, M. (Author)
Format: Article
Language:English
Published: Academy of Managed Care Pharmacy (AMCP) 2021
Subjects:
abiraterone
access to information
adolescent
Adolescent
adult
Adult
aged
Aged
Aged, 80 and over
Ambulatory Care Facilities
antineoplastic agent
Antineoplastic Agents
Article
breast cancer
capecitabine
chronic lymphatic leukemia
clinical pharmacist
cost control
Cost Savings
cutaneous T cell lymphoma
Delivery of Health Care, Integrated
documentation
economics
electronic health record
female
Female
financial stress
follow up
gilteritinib
hospital pharmacy
human
Humans
ibrutinib
insurance
integrated health care system
male
Male
medicaid
medicare
middle aged
Middle Aged
neoplasm
Neoplasms
observational study
Ohio
outpatient department
palbociclib
patient safety
pharmacy benefit manager
Pharmacy Service, Hospital
Practice Patterns, Pharmacists'
prescription
prostate cancer
Retrospective Studies
retrospective study
specialty pharmacy
very elderly
young adult
Young Adult
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items